https://biotechpharmainvestor.substack.comBackground: Physician involved in clinical research. Investment style: Clinical-stage biotech stocks, long only, both long-term ideas and event-driven trading. My academic/medical background helps me evaluate the scientific fundamentals of biotech stocks.Due to seeking alpha rules I cannot cover here all stocks that I am following/trading. I write about such stock in substack.Analyst’s Disclosure:I/we have a beneficial long position in the shares of DTIL either thro ...

文章核心观点 - 文章作者是一位参与临床研究的医生 其投资风格专注于临床阶段生物技术股票 采取纯多头策略 包括长期投资和事件驱动交易 其学术和医学背景有助于评估生物技术股票的科学基本面 [1] 分析师背景与披露 - 分析师在DTIL公司拥有多头权益 可能通过股票、期权或其他衍生工具持有 [2] - 该文章为分析师个人所写 表达其个人观点 除Seeking Alpha外未获得其他报酬 与文中提及的任何公司无业务关系 [2]